CCMD
EMN icon

Cypress Capital Management (Delaware)’s Eastman Chemical EMN Stock Holding History

Cypress Capital Management (Delaware)’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,620
Closed -$648K – 114
2016
Q4 		$648K Buy
+8,620
New +$623K 0.17% 61

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cypress Capital Management (Delaware)'s EMN Position: Q1 2017 in Review

Cypress Capital Management (Delaware) sold out of Eastman Chemical (EMN) in Q1 2017, closing a stake of 8,620 shares — an estimated $648K sold.

Cypress Capital Management (Delaware) first reported a position in EMN in Q4 2016 and held it in 1 quarter. The position peaked at $648K in Q4 2016. 605 funds tracked by Wall St. Rank hold EMN as of Q1 2017.

  • Cypress Capital Management (Delaware) reported no remaining Eastman Chemical position as of Q1 2017 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 8,620 Eastman Chemical shares in Q1 2017, an estimated $648K.
  • Cypress Capital Management (Delaware) first reported a position in Eastman Chemical in Q4 2016 and held it in 1 quarter.
  • Cypress Capital Management (Delaware)'s Eastman Chemical position peaked at $648K in Q4 2016.
  • 605 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2017.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q1 2017, filed 2 May 2017.